392 related articles for article (PubMed ID: 34135913)
41. Prognostic value of an eighteen-genes panel in acute myeloid leukemia by analyzing TARGET and TCGA databases.
Chen P; Cao J; Chen L; Gao G; Xu Y; Jia P; Li Y; Li Y; Du J; Zhang S; Zhang J
Cancer Biomark; 2023; 36(4):287-298. PubMed ID: 36938728
[TBL] [Abstract][Full Text] [Related]
42. A novel prognostic model of methylation-associated genes in acute myeloid leukemia.
Chen M; Zeng Z; Qin W; Cai X; Lu X; Chen S
Clin Transl Oncol; 2023 Jun; 25(6):1719-1728. PubMed ID: 36715873
[TBL] [Abstract][Full Text] [Related]
43. A telomere-related gene risk model for predicting prognosis and treatment response in acute myeloid leukemia.
Shi HZ; Wang MW; Huang YS; Liu Z; Li L; Wan LP
Heliyon; 2024 Jun; 10(11):e31705. PubMed ID: 38845982
[TBL] [Abstract][Full Text] [Related]
44. Exploration of cuprotosis-related genes for predicting prognosis and immunological characteristics in acute myeloid leukaemia based on genome and transcriptome.
Wei Y; Miao Z; Guo X; Feng S
Aging (Albany NY); 2023 Jul; 15(13):6467-6486. PubMed ID: 37450406
[TBL] [Abstract][Full Text] [Related]
45. Characterization of protein-based risk signature to predict prognosis and evaluate the tumor immune environment in breast cancer.
Qing X; Yuan C; Wang K
Breast Cancer; 2023 May; 30(3):424-435. PubMed ID: 36732487
[TBL] [Abstract][Full Text] [Related]
46. Comprehensive analysis of immune-related lncRNAs in AML patients uncovers potential therapeutic targets and prognostic biomarkers.
Zhang M; Zhang LL; Yi LB; Tu XN; Zhou Y; Li DY; Xue HC; Li YX; Zheng ZZ
Heliyon; 2024 May; 10(9):e30616. PubMed ID: 38774083
[TBL] [Abstract][Full Text] [Related]
47. Expression analysis, clinical significance and potential function of PLXNB2 in acute myeloid leukaemia.
Guo Z; Guo D; Kong D; Bian S; Zhao L; Li Q; Lin L; Hao J; Sun L; Li Y
Mol Biol Rep; 2023 Oct; 50(10):8445-8457. PubMed ID: 37632633
[TBL] [Abstract][Full Text] [Related]
48. Bioinformatics Analysis Identifies EPAS1 as a Novel Prognostic Marker Correlated with Immune Infiltration in Acute Myeloid Leukemia.
Wang S; Zhang P
Dis Markers; 2023; 2023():6072782. PubMed ID: 37124944
[TBL] [Abstract][Full Text] [Related]
49. A Novel Fatty Acid Metabolism-Associated Risk Model for Prognosis Prediction in Acute Myeloid Leukaemia.
Wang N; Bai X; Wang X; Wang D; Ma G; Zhang F; Ye J; Lu F; Ji C
Curr Oncol; 2023 Feb; 30(2):2524-2542. PubMed ID: 36826154
[TBL] [Abstract][Full Text] [Related]
50. Determination of Cuproptosis-related Subtypes, Development of a Prognostic Model, and Characterization of Tumor Microenvironment Infiltration in Acute Myeloid Leukemia.
Tao Y; Ren J; Xue T; Wang Y; Xu H; Zhang H; Lu J
Anticancer Res; 2023 Sep; 43(9):3943-3960. PubMed ID: 37648328
[TBL] [Abstract][Full Text] [Related]
51. The prognostic signature based on glycolysis-immune related genes for acute myeloid leukemia patients.
Hou H; Wu Y; Guo J; Zhang W; Wang R; Yang H; Wang Z
Immunobiology; 2023 May; 228(3):152355. PubMed ID: 36868006
[TBL] [Abstract][Full Text] [Related]
52. Unlocking the potential: A novel prognostic index signature for acute myeloid leukemia.
Zhang LQ; Liang YC; Wang JX; Zhang J; La T; Li QZ
Comput Biol Med; 2024 May; 173():108396. PubMed ID: 38574529
[TBL] [Abstract][Full Text] [Related]
53. Comprehensive bioinformatic analysis of the expression and prognostic significance of TSC22D domain family genes in adult acute myeloid leukemia.
Xu X; Sun R; Li Y; Wang J; Zhang M; Xiong X; Xie D; Jin X; Zhao M
BMC Med Genomics; 2023 May; 16(1):117. PubMed ID: 37237254
[TBL] [Abstract][Full Text] [Related]
54. m
Wen Q; Wang S; Hong L; Shen S; He Y; Sheng X; Zhuang X; Chen S; Wang Y; Zhuang H
Immun Inflamm Dis; 2024 Jan; 12(1):e1150. PubMed ID: 38270308
[TBL] [Abstract][Full Text] [Related]
55. [Prognostic Value of
LE N; Yang JJ; Liu YC; Zhang XW; Wang H; Wen YN; Jiao YF; Wang LL; Dou LP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):355-364. PubMed ID: 38660836
[TBL] [Abstract][Full Text] [Related]
56. Identifying a prognostic model and screening of potential natural compounds for acute myeloid leukemia.
Sun XH; Wan S; Chai YH; Bai XT; Li HX; Xi YM
Transl Cancer Res; 2023 Jun; 12(6):1535-1551. PubMed ID: 37434693
[TBL] [Abstract][Full Text] [Related]
57. Construction and validation of an NAD + metabolism-related lncRNA signature for predicting the prognosis and immune landscape of acute myeloid leukemia.
Zhu Y; Jian J; Niu Y; Yang X; Guo Y; Zhao L; Liu B
Hematology; 2023 Dec; 28(1):2231760. PubMed ID: 37417449
[TBL] [Abstract][Full Text] [Related]
58. Optimal combination of immune checkpoint and senescence molecule predicts adverse outcomes in patients with acute myeloid leukemia.
Wang P; Zhang Y; Cai Q; Long Q; Pan S; Zhou W; Deng T; Mo W; Wang S; Zhang Y; Wang C; Chen C
Ann Med; 2023 Dec; 55(1):2201507. PubMed ID: 37070487
[TBL] [Abstract][Full Text] [Related]
59. Identification and validation of necroptosis-related gene signatures to predict clinical outcomes and therapeutic responses in acute myeloid leukemia.
Wen XM; Xu ZJ; Ma JC; Xia PH; Jin Y; Chen XY; Qian W; Lin J; Qian J
Aging (Albany NY); 2023 Nov; 15(24):14677-14702. PubMed ID: 37993258
[TBL] [Abstract][Full Text] [Related]
60. Single-cell transcriptomic analysis of the immune microenvironment in pediatric acute leukemia.
Yuan J; Zhang J; Zhao B; Liu F; Liu T; Duan Y; Chen Y; Chen X; Zou Y; Zhang L; Guo Y; Yang W; Yang Y; Wei J; Zhu X; Zhang Y
Cancer Lett; 2024 Aug; 596():217018. PubMed ID: 38844062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
